2018
DOI: 10.1038/s41598-018-26078-0
|View full text |Cite
|
Sign up to set email alerts
|

Melanopsin-mediated pupil function is impaired in Parkinson’s disease

Abstract: Parkinson’s disease (PD) is characterised by non-motor symptoms including sleep and circadian disruption. Melanopsin-expressing intrinsically photosensitive Retinal Ganglion Cells (ipRGC) transmit light signals to brain areas controlling circadian rhythms and the pupil light reflex. To determine if non-motor symptoms observed in PD are linked to ipRGC dysfunction, we evaluated melanopsin and rod/cone contributions to the pupil response in medicated participants with PD (n = 17) and controls (n = 12). Autonomic… Show more

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

4
50
3
1

Year Published

2018
2018
2023
2023

Publication Types

Select...
7
1
1

Relationship

1
8

Authors

Journals

citations
Cited by 65 publications
(58 citation statements)
references
References 83 publications
(87 reference statements)
4
50
3
1
Order By: Relevance
“…In the last years the mRGC-mediated pupil light response has been investigated in various neurological disorders, including IIH, MS, and PD (3134).…”
Section: Melanopsin Rgcs and Pupil In Other Neurological Disordersmentioning
confidence: 99%
See 1 more Smart Citation
“…In the last years the mRGC-mediated pupil light response has been investigated in various neurological disorders, including IIH, MS, and PD (3134).…”
Section: Melanopsin Rgcs and Pupil In Other Neurological Disordersmentioning
confidence: 99%
“…The PLR mediated by mRGCs has been investigated in different ophthalmological conditions including glaucoma (1618), retinitis pigmentosa (19), diabetes (20), Leber's congenital amaurosis (14), age-related macular degeneration (21), and ischemic optic neuropathies (22, 23). Moreover, various neurological and psychiatric disorders have been evaluated, including hereditary optic neuropathies (2429), seasonal affective disorder (SAD) (30), idiopathic intracranial hypertension (IIH) (31, 32), multiple sclerosis (MS) (33), and Parkinson's disease (PD) (34).…”
Section: Introductionmentioning
confidence: 99%
“…PIPR measurements have been made in numerous clinical conditions, including multiple sclerosis, Parkinson's disease, idiopathic intracranial hypertension, traumatic brain injury, glaucoma, diabetes, retinitis pigmentosa, Leber's hereditary optic neuropathy, Smith-Magenis syndrome, and depression. 21 32 …”
mentioning
confidence: 99%
“…Particular attention is paid to the behavior of the pupil at relatively delayed time periods, including after stimulus offset (i.e., 'post-illumination'), when melanopsin is found to exert greater influence over pupil size relative to the cones 11,20 . PIPR measurements have been made in numerous clinical conditions, including multiple sclerosis, Parkinson's disease, idiopathic intracranial hypertension, traumatic brain injury, glaucoma, diabetes, retinitis pigmentosa, Leber's hereditary optic neuropathy, Smith-Magenis syndrome, and depression [21][22][23][24][25][26][27][28][29][30][31][32] .…”
Section: Introductionmentioning
confidence: 99%